{"entity":{"id":"idea-acc-hpv-self-sample-same-day-ablation","kind":"idea","name":"HPV self-testing with same-day treatment as the national cervical programme","aka":[],"tldr":"Women can collect their own sample for the virus that causes cervical cancer; those who test positive can be treated the same day with a simple heat device. Done nationally, this could eliminate a disease that still kills hundreds of thousands of women a year.","summary":"WHO's cervical cancer elimination strategy sets 70% screening coverage with a high-performance test and 90% treatment of pre-cancer. Self-collected HPV testing removes the speculum exam that deters women, and portable thermal ablation allows treatment at the point of screening without histology. Point-of-care HPV tests now return results within an hour. The proposal is to make this combination, rather than cytology, the default national programme and fund it as a vertical campaign.","asOf":"2026-09-08","links":[{"label":"WHO cervical cancer elimination initiative","url":"https://www.who.int/initiatives/cervical-cancer-elimination-initiative"}],"tags":[],"related":[],"cancers":["cervical"],"sections":["prevention"],"technologies":["hpv-vaccine"],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":["b-global-access","b-prevention-adoption"],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"hypothesis":"Countries implementing self-sampling plus same-day ablation will reach 70% screening coverage of women aged 35-45 within five years, versus under 20% for cytology-based programmes, and will halve pre-cancer treatment loss to follow-up.","rationale":"Self-sampling roughly doubles participation in trials in Africa and Latin America; screen-and-treat eliminates the second visit that loses most patients.","test":"National rollout with population coverage, positivity, same-day treatment rate, and cervical cancer incidence tracked in the population-based registry over ten years.","maturity":"being-tested-at-scale","actor":"policy","cost":"medium","horizonYears":3},"route":"/ideas/idea-acc-hpv-self-sample-same-day-ablation/","neighbours":{"cancer":[{"id":"cervical","kind":"cancer","name":"Cervical cancer","route":"/cancers/cervical/"}],"section":[{"id":"prevention","kind":"section","name":"Prevention & Risk","route":"/fronts/prevention/"}],"technology":[{"id":"hpv-vaccine","kind":"technology","name":"HPV & HBV vaccination","route":"/technologies/hpv-vaccine/"},{"id":"via-cervical-screening","kind":"technology","name":"Visual inspection with acetic acid (VIA) for cervical screening","route":"/technologies/via-cervical-screening/"}],"bottleneck":[{"id":"b-global-access","kind":"bottleneck","name":"Most of the world has almost no cancer care","route":"/bottlenecks/b-global-access/"},{"id":"b-prevention-adoption","kind":"bottleneck","name":"Prevention we already have is not deployed","route":"/bottlenecks/b-prevention-adoption/"}],"paper":[{"id":"paper-hpv-self-sampling-bmj-2018","kind":"paper","name":"Self-collected HPV samples are as accurate as clinician samples and reach women who never attend screening","route":"/key-papers/paper-hpv-self-sampling-bmj-2018/"}],"roadmap":[{"id":"devices-roadmap","kind":"roadmap","name":"Devices and physical therapies roadmap: heat and light → electric fields and focused sound → drug-releasing implants","route":"/roadmaps/devices-roadmap/"},{"id":"global-access-roadmap","kind":"roadmap","name":"Global access and affordability roadmap: essential medicines and generics → biosimilars and frugal trials → reliance, pooling and homegrown innovation","route":"/roadmaps/global-access-roadmap/"}]}}